Fig. 4 | Scientific Reports

Fig. 4

From: Cilazapril and benazepril mitigate neurodegeneration and α-synuclein accumulation in a cellular model of parkinson’s disease

Fig. 4The alternative text for this image may have been generated using AI.

(a) D1B Receptor-Interaction (2D View) Benazepril is more oriented toward binding sites such as Glu121 and Tyr218. (b) D1B receptor– interaction (3D view) The binding site of benazepril within the D1A receptor is depicted, highlighting the key residues involved in its interaction. The binding pocket is visualized, highlighting its strong interaction through hydrogen bonding and hydrophobic forces.

Back to article page